III. Characteristics and Differences in Pneumococcal Vaccines; 2. Pneumococcal Conjugate Vaccine
openaire +3 more sources
Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review. [PDF]
Shono A, Hoshi SL, Kondo M.
europepmc +1 more source
Eighteen-Year Longitudinal Study of Uncomplicated and Complex Acute Otitis Media During the Pneumococcal Conjugate Vaccine Era, 2006-2023. [PDF]
Fuji N +10 more
europepmc +1 more source
Serotype distribution and antimicrobial susceptibility patterns of Streptococcus pneumoniae isolates in the post-pneumococcal conjugate vaccine era in Nigeria: a hospital-based cross-sectional study. [PDF]
Joy N +6 more
europepmc +1 more source
10-Year Effects of the 13-Valent Pneumococcal Conjugate Vaccine in Patients with Chronic Obstructive Pulmonary Disease and Stable Angina Pectoris. [PDF]
Ignatova GL +4 more
europepmc +1 more source
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial. [PDF]
Gallagher KE +20 more
europepmc +1 more source
Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea. [PDF]
Choe YJ +11 more
europepmc +1 more source
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]
Ngamprasertchai T +2 more
europepmc +1 more source
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants. [PDF]
Pichon S +12 more
europepmc +1 more source
Assessing the Impact of Pneumococcal Conjugate Vaccines
openaire +2 more sources

